Skip to main content

Table 3 The association between the EAT-Lancet reference diet and all-cause mortality in cancer survivors of selected primary cancer types

From: Higher adherence to the EAT-Lancet reference diet is inversely associated with mortality in a UK population of cancer survivors

 

Breast cancer (n = 8783)

Colorectal cancer (n = 2074)

Prostate cancer (n = 2959)

  

HR (95% CI)

 

HR (95% CI)

 

HR (95% CI)

 

Events, n

Model 1 a

Model 2 b

Events, n

Model 1 a

Model 2 b

Events, n

Model 1 a

Model 2 b

Continuous

1360

0.96 (0.93–0.99)

0.95 (0.92–0.99)

450

0.96 (0.90–1.03)

0.98 (0.92–1.05)

634

1.07 (1.01–1.12)

1.06 (1.01–1.12)

Tertile 1

655

Ref

Ref

236

Ref

Ref

291

Ref

Ref

Tertile 2

329

0.94 (0.82–1.07)

0.94 (0.82–1.07)

117

1.09 (0.87–1.37)

1.13 (0.90–1.43)

150

0.99 (0.81–1.21)

0.96 (0.78–1.17)

Tertile 3

377

0.87 (0.77–0.99)

0.86 (0.76–0.98)

97

0.83 (0.65–1.06)

0.88 (0.68–1.13)

193

1.21 (1.00–1.45)

1.18 (0.98–1.43)

  1. aModel based on age, sex, and region
  2. bModel based on age, sex, and region plus further adjustment for education, Townsend deprivation index, smoking status, body mass index, physical activity, alcohol consumption, self-reported changes in the diet in the past 5 years, and time between the initial cancer diagnosis and study recruitment
  3. Abbreviations: CI, confidence interval, HR, hazard ratio. In analyses with breast and prostate cancer as outcomes, only participants with reported sex as female and male, respectively, were included